版本:
中国

BRIEF-Vivus reacquires Stendra(R)(AVANAFIL)commercial rights from Sanofi

March 27 Vivus Inc

* Reacquires Stendra(R) (Avanafil) commercial rights from Sanofi

* Says Sanofi will provide transition services to avoid adverse impacts to regulatory approval applications in process

* Agreement with Sanofi to return commercial rights for Stendra in Africa, Middle East, Turkey, Commonwealth Of Independent States, including Russia, to Co Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐